Contralateral breast cancer risk with radiation therapy in BRCA mutation carriers: what do we tell patients? [PDF]
Lee MK, Robson ME.
europepmc +1 more source
Evaluating high-risk breast cancer surveillance outcomes in BRCA mutation carriers. [PDF]
Chang YK, Luk WP, Fung LH, Kwong A.
europepmc +1 more source
BRCA mutation status and olaparib-related toxicity during maintenance therapy: a real-world retrospective cohort study. [PDF]
Gao Y, Gai M, Zhang H, Li H.
europepmc +1 more source
Habitat radiomics based on CT for assessing BRCA mutation status in patients with high-grade serous ovarian cancer: a multicenter study. [PDF]
Zhang S +7 more
europepmc +1 more source
Overview on population screening for carriers with germline BRCA mutation in China. [PDF]
Lei H +5 more
europepmc +1 more source
Does BRCA Mutation Status Influence Ovarian Cancer Onset Timing and Patients' Treatment Outcomes? [PDF]
Michalczyk K +5 more
europepmc +1 more source
A novel BRCA mutation classification system reveals differential responses to PARP inhibition and prognostic outcomes in epithelial ovarian cancer: a multicenter study. [PDF]
Liu Q +18 more
europepmc +1 more source
The impact of BRCA mutation and hormone receptor status on the outcomes of fertility preservation in breast cancer patients: a systematic review and meta-analysis. [PDF]
Ye L, Yang W, Guan H.
europepmc +1 more source
Real-World Epidemiology, Clinical Characteristics and Outcomes of Women with Germline BRCA Mutation and Early Breast Cancer in China. [PDF]
Hu Z +11 more
europepmc +1 more source

